UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004882 |
|---|---|
| Receipt number | R000003868 |
| Scientific Title | Multicenter Phase II trial of Irinotecan plus S-1 with cetuximab (IRIS/Cet) in patients with EGFR positive and KRAS wild type of advanced/metastatic colorectal cancer |
| Date of disclosure of the study information | 2011/01/15 |
| Last modified on | 2015/07/15 10:14:32 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/01/15 04:34:57 | ||
| 2 | Update | 2011/06/21 11:40:51 | Recruitment status |
|
| 3 | Update | 2011/07/17 12:19:37 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 4 | Update | 2012/01/15 09:19:28 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2013/07/15 09:35:06 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2014/01/15 10:11:02 | Email Division name |
|
| 7 | Update | 2014/01/15 10:12:08 | Recruitment status Publication of results |
|
| 8 | Update | 2015/07/15 10:14:32 | Recruitment status |
